Incannex Healthcare Inc. (IXHL)

NasdaqCM: IXHL · リアルタイム株価 · USD

3.57

-0.05 (-1.38%)

終値時点： Aug 21, 2026, 3:59 PM

3.54

-0.84%

時間外: 7:57 PM

株価、主要な数字、最新ニュースをひとまとめにしたページです。

-1.38% (1D)

買気配	2.56
時価総額	42.71M
売上高（TTM）	n/a
純利益（TTM）	-48.41M
	2.81
	-16.62
	n/a
	-2.07
PBR（TTM）	0.65
PSR（TTM）	n/a
決算発表日	n/a

売気配	4.58
出来高	69,759
平均出来高（20日）	208,819
始値	3.57
前日終値	3.62
当日レンジ	3.51 - 3.65
52週レンジ	2.49 - 27.69
アナリスト	n/a
目標株価	n/a
配当	n/a
権利落ち日	n/a

IXHLについて

Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical deve...

[続きを読む]

業種 Drug Manufacturers - Specialty & Generic

セクター Healthcare

IPO日 Mar 2, 2022

従業員数 12

上場取引所 NasdaqCM

ティッカー IXHL

ウェブサイト https://www.incannex.com

企業情報の全文

業績

2024年のIncannex Healthcareの売上高は12Kで、前年の0からundefined%の増加でした。利益は-18.46Mで、-62.18%の減少でした。

財務諸表

決算サプライズ

Incannex HealthcareはMay 15, 2026に四半期決算を発表しました：

売上高は $0 で、予想を下回りました $0, うち NaN% の前年比増加にあたります.
EPSは -0.49 で、予想を上回りました 0.35, うち 94.78% の前年比増加にあたります.

ニュース

1か月前 · Insider Monkey

Incannex (IXHL) Secures U.S. Patent Grant in Obstructive Sleep Apnea for IHL-42X

Incannex Healthcare Inc. (NASDAQ:IXHL) is one of the best strong buy penny stocks to invest in now. Incannex Healthcare Inc. (NASDAQ:IXHL) announced on June 25 the granting of a key patent by the Unit...

5か月前 · Insider Monkey

Incannex Healthcare Inc. (IXHL) Implements 1-for-30 Reverse Split Effective February 26

Incannex Healthcare Inc. (NASDAQ:IXHL) is among the 11 Best Pot Stocks to Buy According to Hedge Funds. On February 25, Incannex Healthcare Inc. (NASDAQ:IXHL) announced that its board of directors app...

6か月前 · Market Exclusive

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Key Takeaways; Cannabis Sector Tilray Rebranded Italian Medical Cannabis Arm as Tilray Medical Italia Aurora Cannabis Won EU-wide Protection for its Farm Gas and Sourdough Cannabis Varieties Simply So...

8か月前 · Zacks

What Makes Incannex Healthcare Inc. (IXHL) a New Buy Stock

Incannex Healthcare Inc. (IXHL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Incannex Healthcare Inc. (IXHL)